Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%
- Check22 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0; page now reflects the newer revision (v3.1.0).SummaryDifference0.0%
- Check36 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as updates to the content related to drug therapy and specific medicines like pembrolizumab. Notably, the revision number has been updated to v3.0.0.SummaryDifference1%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.